Chemistfrog
Long only, growth, momentum, contrarian

Acasti Pharma: Increasing Investor Interest And Volatility Likely Cometh

Acasti Pharma's (ACST) last three weeks of trading have been indicative of increasing investor interest. June 28th's closing at $2.83 represented a solid close above former resistance in the $2.70s that had been the stock's bane since December 2012, January of this year and multiple times in May and June. Reviewing the company's stock chart for 2013, March 21st's $2.10 closing lows have been followed by a bullish uptrend with 52-week closing highs of $3.00 on July 8th. When researching new investment candidates, SEC filings and corporate press releases around such peaks and dips can be very revealing and can reveal upcoming or even imminent catalysts. Although currently a somewhat illiquid stock, I believe investors with a higher...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details